MedPath

estimation of Iron levels in women with hair loss

Phase 3
Conditions
Health Condition 1: null- hair loss for more than three months
Registration Number
CTRI/2011/05/001710
Lead Sponsor
prince aly khan hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Women with telogen effluvium.

Age : 18-40 years.

Normal menses history.

Hair loss of more than 3 month.

Compliant patient.

Exclusion Criteria

Irregular menses.

Pregnancy

Polycystic Ovarian Disease (PCOD)

Thyroid dysfunction

Patient on iron supplements

Androgenetic alopecia

Alopecia areata

Patient on anti cancer / anti metabolic drugs

Recent blood transfusion

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To estimate and evaluate serum iron, serum ferritin level and TIBG in women with hair loss. <br/ ><br>2.TO detect the above parameters in women with telogen effluvium over 3 months and statistically analyse the proportion of overt iron deficiency in women who have long standing telogen effluvium. <br/ ><br>Timepoint: 1. to estimate and evaluate serum iron, serum ferritin level and TIBG in women with hair loss. <br/ ><br>2.TO detect the above parameters in women with telogen effluvium over 3 months and statistically analyse the proportion of overt iron deficiency in women who have long standing telogen effluvium. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To rationalise by statistical evaluation wether iron and serum ferritin test results are significant for hair lossTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath